等待開盤 11-01 09:30:00 美东时间
+0.025
+0.12%
 華盛通
華盛通DUBLIN, Oct. 29, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer health products, today announced that its Board of Directors declared a quarterl...
10-29 23:57
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
Jefferies analyst Keith Devas maintains Perrigo (NYSE:PRGO) with a Hold and lowers the price target from $27 to $23.
10-27 21:21
During times of turbulence and uncertainty in the markets, many investors turn ...
10-15 19:15
https://truthsocial.com/@realDonaldTrump/posts/115267512131958759
09-26 13:43
https://teamster.org/2025/09/perrigo-teamsters-in-new-york-launch-strike/
09-06 03:03
DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and ...
08-20 19:30
Perrigo faces a legal battle over whether major investor Sculptor can exit a securities class action years after missing the opt-out deadline amid $1 billion restatements.
08-14 02:28
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
08-08 09:34
JP Morgan analyst Chris Schott maintains Perrigo (NYSE:PRGO) with a Overweight and lowers the price target from $38 to $35.
08-08 05:19